Atopia Therapeutics, Formerly HpVac, Announces Appointment of Dr. Gregoire Chevalier as CEO and ...
Geneva (Switzerland), May 7, 2024 – Atopia Therapeutics, a leader in the development of breakthrough asthma and allergy therapies, today announced the appointment of Dr. Grégoire Chevalier as Chief Executive
Jeffrey Shaw Jacques Billy Ludger Wess Ines Regina Buth Innovation Center Atopia Therapeutics Chief Executive Officer
Source: smdailyjournal.com